Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Dianthus Therapeutics, Inc. (DNTH) had Weighted-Average Shares Outstanding (Diluted) of 37.79M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
$0.40M |
|
$-36.77M |
|
-- |
|
$0.40M |
|
$40.68M |
|
$-40.29M |
|
$3.52M |
|
$-36.77M |
|
$-36.99M |
|
$-36.77M |
|
$-36.77M |
|
$-36.77M |
|
$-36.99M |
|
$-40.29M |
|
$-42.50M |
|
37.79M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
37.79M |
$-0.97 |
|
$-0.97 |
|
| Balance Sheet Financials | |
$413.82M |
|
$0.18M |
|
$163.62M |
|
$577.45M |
|
$23.86M |
|
-- |
|
$7.14M |
|
$30.99M |
|
$546.45M |
|
$546.45M |
|
$546.45M |
|
42.85M |
|
| Cash Flow Statement Financials | |
$-82.08M |
|
$-160.04M |
|
$275.24M |
|
$23.02M |
|
$56.15M |
|
$33.13M |
|
$16.82M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
17.35 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-10173.74% |
|
-10173.74% |
|
-- |
|
-9284.09% |
|
-9284.09% |
|
$-82.15M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
0.08 |
|
1136.36 |
|
-6.73% |
|
-6.73% |
|
-6.37% |
|
-6.73% |
|
$12.75 |
|
$-2.17 |
|
$-2.17 |
|